Yoga Plus Aerobics Beneficial in Coronary Heart Disease
FRIDAY, Oct. 20, 2017 -- For coronary heart disease patients with type 2 diabetes, combined Indian yoga and aerobic exercise is associated with greater improvement in heart disease risk factors than yoga or aerobic exercise alone, according to a study presented at the 8th Emirates Cardiac Society Congress in collaboration with the American College of Cardiology Middle East Conference, being held Oct. 19 to 21 in Dubai.
Sonal Tanwar, Ph.D., and Naresh Sen, D.M., Ph.D., from HG SMS Hospital in India, randomized patients diagnosed with coronary heart disease to one of three groups: aerobic exercise (group 1, 225 individuals), Indian-specific yoga for heart disease and diabetes (group 2, 240 patients), or Indian-specific yoga plus aerobic exercise (group 3, 285 individuals).
The researchers found that the results were similar in groups 1 and 2 for reduction of blood pressure, total cholesterol, triglyceride and low-density lipoprotein, weight reduction, waist circumference reduction, and improved angina (P < 0.05). Compared with individual groups, group 3 had about twofold greater reductions in blood pressure, body mass index, and cholesterol (P < 0.04). Compared with groups 1 and 2, group 3 also had significant improvement of left ventricular ejection fraction, diastolic function, six-minute walk or exercise capacity, heart rate recovery, and class of dyspnea/angina (P < 0.05, 0.003).
"Combined Indian yoga and aerobic exercise reduce mental, physical, and vascular stress and can lead to decreased cardiovascular mortality and morbidity," the authors said in a statement.
© 2020 HealthDay. All rights reserved.
Posted: October 2017
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.